-
Arimoclomol (INN;
originally codenamed BRX-345,
which is a
citrate salt
formulation of BRX-220) is an
experimental drug
developed by
CytRx Corporation...
- 2014, the
European Medicines Agency granted orphan drug
designation to
arimoclomol for the
treatment of Niemann–Pick type C. This was
followed in 2015 by...
- Niemann–Pick type C (for
patients with both type C1 and C2)
using arimoclomol began in 2016.
Arimoclomol,
which is
orally administered,
induces the heat
shock response...
- lost over half of its
share value overnight upon
disclosing a CRL for
arimoclomol, a
proposed treatment for Niemann–Pick disease, type C,
forcing the company...
- N07XX14
Edaravone N07XX15
Inotersen N07XX16 Deutetrabe****ne N07XX17
Arimoclomol N07XX18
Vutrisiran N07XX19
Sodium phenylbutyrate and ursodoxicoltaurine...
- acid,
lithium carbonate, pioglitazone, Ono-2506 (arundic acid), and
arimoclomol.
Repetitive transcranial magnetic stimulation had been
studied in amyotrophic...
